A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
about
Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolveCellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationEmerging targeted therapies for glioma.Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiformeMR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.Toward precision medicine in glioblastoma: the promise and the challenges.Glioblastoma targeted therapy: updated approaches from recent biological insights.Inhibiting 4EBP1 in glioblastoma.Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.Investigational new drugs for brain cancer.Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain CancerPI3K pathway inhibition in GBM—is there a signal?mTOR-Dependent Cell Proliferation in the Brain.Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol.A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913.Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease
P2860
Q26764947-05793D18-B650-47FC-BC02-D6F07C044043Q26771165-95E76BCE-AEE9-4A5A-9D45-FBFBF8A19B2BQ30241853-F6F393C6-7F51-49A5-BADD-950E82288E4EQ36658345-38B6C1E8-A6EB-494E-9C62-B8A4E1111F1DQ36918102-F7BF9C7C-194A-49C3-82A3-E8A93FD0D162Q36939659-AF689C94-B86E-488F-ABD6-3648C3FC7FE0Q38454659-75A60359-8466-447E-B760-EDEFFF021348Q38597700-27D98986-1AAA-41B6-82B1-7E252F2501D8Q38659417-78FB5FD3-D14D-4757-85F8-ECC94A193370Q38676891-DCC9A31F-C211-4FBD-989B-EA35B884FDA4Q38832510-52AE6EF7-320C-49C1-ADD8-9F30EDD77314Q39139224-B03DD6C5-431A-4AE1-9F38-A76B68D93A87Q39337955-C0AB4F51-5F8A-40ED-8440-7CB063E6BCF4Q43236110-1B757901-E98C-4984-A6EC-F08645960F16Q47231432-3D62F92F-D42C-45D3-9308-CFB9491FE27BQ47770490-B7ABFE9E-0435-4A4D-82BF-EB0AAC3FB966Q50068283-8B31F8E8-DD0C-4E20-B7C0-3C1E739A0C39Q50290480-924BB547-C14D-40EE-9980-18D14827F7FEQ52590668-2CDDE491-3882-4CBC-BEF0-31CA8F5B6278Q55262612-301617B2-A154-455B-ABBA-58CE7EAC92D4Q57174537-1981BE39-FC25-47EE-BAE8-B112CDBD8CAD
P2860
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@ast
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@en
type
label
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@ast
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@en
prefLabel
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@ast
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@en
P2093
P2860
P356
P1433
P1476
A phase II trial of everolimus ...... osed glioblastoma: NCCTG N057K
@en
P2093
Caterina Giannini
Daniel J Ma
David Schiff
Jan C Buckner
Jann N Sarkaria
Joon H Uhm
Keith L Ligon
Kurt A Jaeckle
Patrick J Flynn
Patrick J Peller
P2860
P304
P356
10.1093/NEUONC/NOU328
P577
2014-12-18T00:00:00Z